Stock Screener App

Frei -

Installieren

25.17

8.04% -2.20

after-market

Handel nachbörslich: 25.15 -0.02 -0.08%

Viking Therapeutics Inc (VKTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	19.21% 132.60	164.12	164.74	98.56	74.57
Operating Income/Loss	19.21% -132.60	-164.12	-164.74	-98.56	-74.57
Net Income/Loss	19.14% -128.02	-158.32	-157.66	-90.79	-65.56
Basic Average Shares	0.60% 116.26	115.57	0.45	112.32	112.13
Diluted Average Shares	0.60% 116.26	115.57	0.45	112.32	112.13
Basic Earnings Per Share	19.71% -1.10	-1.37	-1.39	-0.81	-0.58
Diluted Earnings Per Share	19.71% -1.10	-1.37	-1.39	-0.81	-0.58

TARS

$68.07

4.11%

IDYA

$32.85

2.95%

XENE

$33.49

2.45%

ACAD

$19.12

2.99%

RLAY

$16.28

5.90%

RCUS

$22.12

3.07%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters